CN102697942A - Medicament capable of killing cancer cells and curing various tumors and cancers and leukemia - Google Patents
Medicament capable of killing cancer cells and curing various tumors and cancers and leukemia Download PDFInfo
- Publication number
- CN102697942A CN102697942A CN2012100004427A CN201210000442A CN102697942A CN 102697942 A CN102697942 A CN 102697942A CN 2012100004427 A CN2012100004427 A CN 2012100004427A CN 201210000442 A CN201210000442 A CN 201210000442A CN 102697942 A CN102697942 A CN 102697942A
- Authority
- CN
- China
- Prior art keywords
- cancer
- parts
- cancers
- radix
- leukemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a medicament-tumor number 1 capable of killing cancer cells and curing various tumors and cancers and leukemia. The medicament comprises glossy ganoderma, ginseng, herba epimedii, astragalus membranaceus, giant knotweed rhizome, Chinese caterpillar fungus, heartleaf houttuynia herb and liquorice root. The medicament capable of killing cancer cells and curing various tumors and cancers and leukemia is prepared by pure traditional Chinese medicine, is good in treatment effects, less in side effects, short in treatment course and the like, is rapid in effect and high in cure rate, has effects of killing cancer cells and improving human body immunity, has functions of prolonging life and anti-aging and is capable of curing leukemia and various tumors and cancers, such as leukemia, bone cancer, lymphoma, intestinal cancer, liver cancer, renal carcinoma, gastric cancer, pelvic cancer, uterine cancer, cervical cancer, bladder cancer, prostatic cancer, pancreatic cancer, lung cancer, brain cancer, neuroendocrine tumor, mammary cancer and esophageal cancer.
Description
[technical field]
The present invention relates to a kind of pharmaceutical formulation, relate in particular to a kind of a kind of ability kill cancer cell that can treat multiple disease simultaneously and cure various tumor and cancers and leukemic medicine.
[background technology]
In process is cured the disease in present clinical application, generally all be to be main with the single relatively medicine of function, can not satisfy the requirement of the multiple disease of treatment.And because existing medicine a multitude of names, general patient is difficult to select the medicine treatment according to self disease oneself.
In addition, it is Western medicine greatly that existing medicine has, and not only expensive makes general ordinary people be difficult to bear, and has toxic and side effects usually, and patient is long-term or take in a large number and can cause the human body viscera damage and develop immunity to drugs, thoroughly radical curing of disease.Some people also can produce the phenomenon of vomiting when taking Western medicine, thereby has increased patient's misery.
In this case, people turn to the traditional Chinese medical science to the hope of treatment.Yet, the medicine that still unmatchful multiple disease can be treated simultaneously in the traditional Chinese medical science at present.
Therefore, for avoiding the problems referred to above, necessaryly provide a kind of and can cure various tumor and cancers and leukemic medicine by kill cancer cell, to overcome said defective of the prior art.
[summary of the invention]
For addressing the above problem, the object of the present invention is to provide a kind of therapeutic effect good, side effect is little, short treating period, and can treat a kind of of multiple disease simultaneously and can cure various tumor and cancers and leukemic medicine by kill cancer cell.
For realizing above-mentioned purpose, the technical scheme that the present invention takes is: a kind of ability kill cancer cell cured various tumor and cancers and leukemic medicine, and it comprises Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, Herba Houttuyniae and Radix Glycyrrhizae.
A kind of ability kill cancer cell of the present invention cures various tumor and cancers and leukemic medicine further is: said Ganoderma, and Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, the proportioning of Herba Houttuyniae and Radix Glycyrrhizae is (parts by weight are represented): 10~14 parts of Ganodermas; 7~9 parts of Radix Ginsengs; 15~20 parts of Herba Epimedii; 9~11 parts of the Radixs Astragali; 10~12 parts of Rhizoma Polygoni Cuspidati; 6~8 parts of Cordycepses; 11~15 parts of Herba Houttuyniae; 11~15 parts in Radix Glycyrrhizae.
A kind of ability kill cancer cell of the present invention cures various tumor and cancers and leukemic medicine further is: said Ganoderma, and Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, the proportioning of fish raw meat leather and Radix Glycyrrhizae is (parts by weight are represented): 11 parts of Ganodermas; 8 parts of Radix Ginsengs; 17 parts of Herba Epimedii; 10 parts of the Radixs Astragali; 11 parts of Rhizoma Polygoni Cuspidati; 7 parts of Cordycepses; 12 parts of Herba Houttuyniae; 12 parts in Radix Glycyrrhizae.
Of the present invention a kind of can kill cancer cell cure various tumor and cancers and leukemic medicine can also for: said pharmaceutical formulation can be processed tablet, capsule, electuary, oral liquid or injection.
Compared with prior art, the present invention has following beneficial effect: of the present inventionly a kind ofly can kill cancer cell cure various tumor and cancers and leukemic medicine is that pure Chinese medicine is processed, it is good to have a therapeutic effect, and side effect is little, plurality of advantages such as short treating period; Simultaneously; This pharmaceutical formulation can treat simultaneously leukemia, osteocarcinoma, lymphatic cancer, intestinal cancer, hepatocarcinoma, renal carcinoma, gastric cancer, pelvic cancer, uterus carcinoma, cervical cancer, bladder cancer, carcinoma of prostate, cancer of pancreas, pulmonary carcinoma, the brain cancer, neural cancer, breast carcinoma, esophageal carcinoma, etc. various tumor and cancers and the multiple disease of leukemia; Have kill cancer cell and the effect that improves body immunity, also have the anti-aging effect of life lengthening.
[specific embodiment]
Below in conjunction with embodiment the present invention is done further explanation.
Embodiment 1:
A kind of ability kill cancer cell of the present invention cures various tumor and cancers and leukemic medicine is made up of following Chinese medicine: Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, Herba Houttuyniae and Radix Glycyrrhizae.Wherein, said Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, the proportioning of Herba Houttuyniae and Radix Glycyrrhizae is (parts by weight are represented): 10~14 parts of Ganodermas; 7~9 parts of Radix Ginsengs; 15~20 parts of Herba Epimedii; 9~11 parts of the Radixs Astragali; 10~12 parts of Rhizoma Polygoni Cuspidati; 6~8 parts of Cordycepses; 11~15 parts of Herba Houttuyniae; 11~15 parts in Radix Glycyrrhizae.Said pharmaceutical formulation is processed tablet, capsule, and electuary, oral liquid or injection are to satisfy the many-sided demand of patient.
Embodiment 2:
A kind of ability kill cancer cell of the present invention cures various tumor and cancers and leukemic medicine is made up of following Chinese medicine: Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, Herba Houttuyniae and Radix Glycyrrhizae.Wherein, said Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, the proportioning of Herba Houttuyniae and Radix Glycyrrhizae is (parts by weight are represented): 11 parts of Ganodermas; 8 parts of Radix Ginsengs; 17 parts of Herba Epimedii; 10 parts of the Radixs Astragali; 11 parts of Rhizoma Polygoni Cuspidati; 7 parts of Cordycepses; 12 parts of Herba Houttuyniae; 12 parts in Radix Glycyrrhizae.Said pharmaceutical formulation is processed tablet, capsule, and electuary, oral liquid or injection are to satisfy the many-sided demand of patient.
Of the present inventionly a kind ofly can kill cancer cell cure various tumor and cancers and leukemic medicine is that pure Chinese medicine is processed, it is good to have a therapeutic effect, and side effect is little, plurality of advantages such as short treating period; Simultaneously, this pharmaceutical formulation can be treated multiple disease simultaneously, has kill cancer cell and the effect that improves body immunity, also has the anti-aging effect of life lengthening.Treatment leukemia, osteocarcinoma, lymphatic cancer, intestinal cancer, hepatocarcinoma, renal carcinoma, gastric cancer, pelvic cancer, uterus carcinoma, cervical cancer, bladder cancer, carcinoma of prostate, cancer of pancreas, pulmonary carcinoma, the brain cancer, neural cancer, breast carcinoma, esophageal carcinoma, etc. various tumor and cancers and leukemia.The high characteristics of instant effect cure rate are arranged.
The above specific embodiment is merely the preferred embodiment of this creation, not in order to limiting this creation, any modification of being made within all spirit and principles in this creation, is equal to replacement, improvement etc., all should be included within the protection domain of this creation.
Claims (4)
1. an ability kill cancer cell is cured various tumor and cancers and leukemic medicine, it is characterized in that: comprise Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, Herba Houttuyniae and Radix Glycyrrhizae.
2. a kind of ability kill cancer cell as claimed in claim 1 cured various tumor and cancers and leukemic medicine, it is characterized in that: said Ganoderma, and Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, the proportioning of Herba Houttuyniae and Radix Glycyrrhizae is (parts by weight are represented):
10~14 parts of Ganodermas;
7~9 parts of Radix Ginsengs;
15~20 parts of Herba Epimedii;
9~11 parts of the Radixs Astragali;
10~12 parts of Rhizoma Polygoni Cuspidati;
6~8 parts of Cordycepses;
11~15 parts of Herba Houttuyniae;
11~15 parts in Radix Glycyrrhizae.
3. a kind of ability kill cancer cell as claimed in claim 2 cured various tumor and cancers and leukemic medicine, it is characterized in that: said Ganoderma, Radix Ginseng; Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati; Cordyceps, the proportioning of Herba Houttuyniae and Radix Glycyrrhizae is (parts by weight are represented): 11 parts of Ganodermas; 8 parts of Radix Ginsengs; 17 parts of Herba Epimedii; 10 parts of the Radixs Astragali; 11 parts of Rhizoma Polygoni Cuspidati; 7 parts of Cordycepses; 12 parts of Herba Houttuyniae; 12 parts in Radix Glycyrrhizae.
4. a kind of ability kill cancer cell as claimed in claim 3 cured various tumor and cancers and leukemic medicine, and it is characterized in that: said pharmaceutical formulation can be processed tablet, capsule, electuary, oral liquid or injection.Treatment leukemia, osteocarcinoma, lymphatic cancer, intestinal cancer, hepatocarcinoma, renal carcinoma, gastric cancer, pelvic cancer, uterus carcinoma, cervical cancer, bladder cancer, carcinoma of prostate, cancer of pancreas, pulmonary carcinoma, the brain cancer, neural cancer, breast carcinoma, esophageal carcinoma, etc. various tumor and cancers and leukemia.The high characteristics of instant effect cure rate are arranged.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100004427A CN102697942A (en) | 2012-01-04 | 2012-01-04 | Medicament capable of killing cancer cells and curing various tumors and cancers and leukemia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100004427A CN102697942A (en) | 2012-01-04 | 2012-01-04 | Medicament capable of killing cancer cells and curing various tumors and cancers and leukemia |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102697942A true CN102697942A (en) | 2012-10-03 |
Family
ID=46891189
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012100004427A Pending CN102697942A (en) | 2012-01-04 | 2012-01-04 | Medicament capable of killing cancer cells and curing various tumors and cancers and leukemia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102697942A (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102861078A (en) * | 2012-10-27 | 2013-01-09 | 吴俊华 | Application of Houttuynoid D in medicine for treating prostatic cancer |
CN102861074A (en) * | 2012-10-27 | 2013-01-09 | 南京大学 | Application of Houttuynoid B in medicine for treating bladder cancer |
CN104189287A (en) * | 2014-09-15 | 2014-12-10 | 秦银忠 | Traditional Chinese medicine preparation for treating kidney cancer, and preparation method of traditional Chinese medicine preparation |
CN105031389A (en) * | 2015-09-16 | 2015-11-11 | 张翠茹 | Traditional Chinese medicine tablet for restraining malignant tumor breeding in cooperation with radiotherapy and preparing method of traditional Chinese medicine tablet |
CN105106712A (en) * | 2015-09-17 | 2015-12-02 | 王守花 | Nutritional porridge capable of helping postoperative recovery of cancer patient and preparation method thereof |
CN105288365A (en) * | 2015-10-19 | 2016-02-03 | 中国中医科学院广安门医院 | Traditional Chinese medicine composition for postoperative rehabilitation of non-small cell lung cancer and application of traditional Chinese medicine composition |
CN106074986A (en) * | 2016-08-26 | 2016-11-09 | 吕晶晶 | A kind of Chinese medicine composition treating pulmonary carcinoma and preparation method thereof |
CN106798811A (en) * | 2017-04-06 | 2017-06-06 | 相宏杰 | A kind of antineoplastic Chinese medicine composition and its preparation method and application |
CN107096003A (en) * | 2017-06-16 | 2017-08-29 | 广东省中医院 | It is a kind of to treat Chinese medicine composition of prostate cancer and preparation method thereof |
CN108721532A (en) * | 2018-09-20 | 2018-11-02 | 上海国宝企业发展中心 | Chinese medicine composition for auxiliary treatment lung cancer |
-
2012
- 2012-01-04 CN CN2012100004427A patent/CN102697942A/en active Pending
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102861074A (en) * | 2012-10-27 | 2013-01-09 | 南京大学 | Application of Houttuynoid B in medicine for treating bladder cancer |
CN102861078B (en) * | 2012-10-27 | 2014-04-16 | 吴俊华 | Application of Houttuynoid D in medicine for treating prostatic cancer |
CN102861074B (en) * | 2012-10-27 | 2014-04-16 | 南京大学 | Application of Houttuynoid B in medicine for treating bladder cancer |
CN102861078A (en) * | 2012-10-27 | 2013-01-09 | 吴俊华 | Application of Houttuynoid D in medicine for treating prostatic cancer |
CN104189287B (en) * | 2014-09-15 | 2018-02-06 | 秦银忠 | It is a kind of to be used to treat Chinese medicine preparation of kidney and preparation method thereof |
CN104189287A (en) * | 2014-09-15 | 2014-12-10 | 秦银忠 | Traditional Chinese medicine preparation for treating kidney cancer, and preparation method of traditional Chinese medicine preparation |
CN105031389A (en) * | 2015-09-16 | 2015-11-11 | 张翠茹 | Traditional Chinese medicine tablet for restraining malignant tumor breeding in cooperation with radiotherapy and preparing method of traditional Chinese medicine tablet |
CN105106712A (en) * | 2015-09-17 | 2015-12-02 | 王守花 | Nutritional porridge capable of helping postoperative recovery of cancer patient and preparation method thereof |
CN105288365A (en) * | 2015-10-19 | 2016-02-03 | 中国中医科学院广安门医院 | Traditional Chinese medicine composition for postoperative rehabilitation of non-small cell lung cancer and application of traditional Chinese medicine composition |
CN105288365B (en) * | 2015-10-19 | 2019-04-30 | 中国中医科学院广安门医院 | A kind of Chinese medicine composition and application thereof for non-small cell lung cancer postoperative rehabilitation |
CN106074986A (en) * | 2016-08-26 | 2016-11-09 | 吕晶晶 | A kind of Chinese medicine composition treating pulmonary carcinoma and preparation method thereof |
CN106798811A (en) * | 2017-04-06 | 2017-06-06 | 相宏杰 | A kind of antineoplastic Chinese medicine composition and its preparation method and application |
CN107096003A (en) * | 2017-06-16 | 2017-08-29 | 广东省中医院 | It is a kind of to treat Chinese medicine composition of prostate cancer and preparation method thereof |
CN108721532A (en) * | 2018-09-20 | 2018-11-02 | 上海国宝企业发展中心 | Chinese medicine composition for auxiliary treatment lung cancer |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102697942A (en) | Medicament capable of killing cancer cells and curing various tumors and cancers and leukemia | |
CN102247541A (en) | Medicament for treating hepatorenal disease, diabete, asthma, rheumatism, and dermatoma | |
CN104258203A (en) | Traditional Chinese medicine combination for preventing and curing leucopenia caused by radiotherapy | |
CN102697868A (en) | Medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis | |
CN102861193A (en) | Traditional Chinese medicine composition for treating gastric cancer | |
CN102697898A (en) | Medicament for regulating endocrine and curing dysmenorrheal, mammary gland hyperplasia and breast dysplasia | |
CN104305170A (en) | Traditional Chinese medicine food formula for radiotherapy postoperative rehabilitation and preparation method thereof | |
CN102988887A (en) | Chinese medicament for treating ovarian cyst | |
CN103751632A (en) | Medicine for treating breast cancer | |
CN105287944A (en) | Traditional Chinese medicine composition for adjuvant therapy of thyroid cancer | |
CN101953975B (en) | Oral Chinese medicinal herbal tablets for treating tumors and preparation method | |
CN101869638A (en) | Traditional Chinese medicine for treating cancer and preparation method thereof | |
CN102697913B (en) | Antitumor drug composition and preparation method thereof | |
CN102327491A (en) | Medicine for treating venereal diseases, such as prostatosis, condyloma acuminatum, gonorrhea syphilis and aids | |
CN102327493A (en) | Medicine for treating tracheitis, rhinitis, pharyngitis, pneumonectasis, pulmonary heart diseases and asthmatic diseases | |
CN102343038A (en) | Medicament for treating cerebrosis such as hemiplegic cerebral palsy, falling sickness, Parkinson, headache, insomnia and the like | |
CN104083580A (en) | Traditional Chinese medicine for treating senile dementia | |
CN102670817A (en) | Medicament for treating various blood diseases such as thrombocytopenia, purpura and leukaemia | |
CN103768328A (en) | Medicinal magnetic plaster for treating tumors | |
CN102343039A (en) | Drug for treating skin diseases such as psoriasis, leucoderma, ichthyosis, eczema and the like | |
CN102327492A (en) | Medicine for treating amyotrophia and myasthenia, myodystrophy and motor neuron injury | |
CN102343042A (en) | Medicine for treating cardiovascular diseases of hypertension, cardiopathy and cerebral thrombus | |
CN102743710A (en) | Anti-cancer and hemostatic Chinese patent drug | |
CN105250805A (en) | Traditional Chinese medicine for treating postpartum hypogalactia | |
CN105381444A (en) | Traditional Chinese medicine decoction for treating thyroid cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C05 | Deemed withdrawal (patent law before 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20121003 |